AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Bristol-Myers Squibb to Take Part at the Goldman Sachs 12th Annual Healthcare CEOs Unscripted Conference

January 2, 2020 GMT

NEW YORK--(BUSINESS WIRE)--Jan 2, 2020--

Bristol-Myers Squibb Company (NYSE: BMY) will take part in a fireside chat at the Goldman Sachs 12th Annual Healthcare CEOs Unscripted Conference on Thursday, January 9, 2020 in New York. Giovanni Caforio, M.D., chairman and chief executive officer will answer questions at 10:25 a.m. ET.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. Materials related to the presentation will be available at the same website at the start of the live webcast. An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

View source version on businesswire.com:https://www.businesswire.com/news/home/20200102005111/en/

CONTACT: Media:

media@bms.com

609-252-3345Investors:

Tim Power, 609-252-7509,timothy.power@bms.com

Nina Goworek, 908-673-9711,ngoworek@celgene.com

KEYWORD: NEW YORK UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH

SOURCE: Bristol-Myers Squibb Company

Copyright Business Wire 2020.

PUB: 01/02/2020 06:59 AM/DISC: 01/02/2020 06:59 AM

http://www.businesswire.com/news/home/20200102005111/en